6-K 1 a20-37185_16k.htm 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

Form 6-K

 


 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2020

 

Commission File Number: 001-39088

 


 

Aesthetic Medical International Holdings Group Limited

 


 

4068 Qiaoxiang Road, Nanshan District

Shenzhen, Guangdong Province, 518053

People’s Republic of China

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

 

Form 20-F

x

Form 40-F

o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Aesthetic Medical International Holdings Group Limited

 

 

 

By:

/s/ Wu Guanhua

 

Name:

Wu Guanhua

 

Title:

Chief Financial Officer

 

 

 

Date: November 30, 2020

 

 

 

2


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press Release — Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2020 Unaudited Financial Results

 

3